What's breaking now, across thousands of outlets.
The European Medicines Agency begins evaluation of a drug that reached 74% efficacy in trials and could prevent Europe’s main vector-borne infection
We haven't written up this one. El Pais English has the full story — the link below goes straight to it.
The victim, who suffered from schizophrenia, is believed to have died from chest injuries.
The victim, who suffered from schizophrenia, is believed to have died from chest injuries.
The government is expected to scale up investment in local vaccine production as Ghana seeks to strengthen its capacity to supply the African market, Chief Executive Officer of the National Vaccine…
Renewed fighting has pushed Ethiopia's healthcare system close to collapse: "The whole emergency (room) was flooded with war trauma patients," one surgeon says of a brutal week in September.
Kenyatta National Hospital (KNH) has made global medical history after performing two pioneering nerve reconstruction surgeries on patients, including a four-year-old boy who became the world’s…
The FDA approved Sunharbo, a once-daily pill, to cut the risk of another stroke; the trial showed a 26% reduction in ischemic stroke
